BioNTech to Host AI Day as an Edition of its Innovation Series on October 1, 2024
2024年9月17日 - 7:45PM
MAINZ, Germany, September 17, 2024
(GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX,
“BioNTech”), alongside its artificial intelligence (“AI”) company
InstaDeep Ltd. (“InstaDeep”), will host an AI Day, an edition of
BioNTech’s “Innovation Series”, at 09:00 a.m. EDT (3:00 p.m. CEST)
on Tuesday, October 1st, 2024 in London, United Kingdom. The event
will provide an overview of BioNTech’s and InstaDeep’s AI strategy
and capabilities, and the application of AI in BioNTech’s pipeline
and internal processes.
The live webcast of the event will be available
via this link.
A replay of the webcast will be available
shortly after the event’s conclusion and archived on BioNTech’s
website for one year after.
About BioNTechBiopharmaceutical New
Technologies (BioNTech) is a global next generation immunotherapy
company pioneering novel therapies for cancer and other serious
diseases. BioNTech exploits a wide array of computational discovery
and therapeutic drug platforms for the rapid development of novel
biopharmaceuticals. Its broad portfolio of oncology product
candidates includes individualized and off-the-shelf mRNA-based
therapies, innovative chimeric antigen receptor (CAR) T cells,
several protein-based therapeutics, including bispecific immune
checkpoint modulators, targeted cancer antibodies and antibody-drug
conjugate (ADC) therapeutics, as well as small molecules. Based on
its deep expertise in mRNA vaccine development and in-house
manufacturing capabilities, BioNTech and its collaborators are
developing multiple mRNA vaccine candidates for a range of
infectious diseases alongside its diverse oncology pipeline.
BioNTech has established a broad set of relationships with multiple
global and specialized pharmaceutical collaborators, including
Biotheus, DualityBio, Fosun Pharma, Genentech, a member of the
Roche Group, Genevant, Genmab, MediLink, OncoC4, Pfizer and
Regeneron.
For more information, please visit
www.BioNTech.com.
CONTACTS
Media RelationsJasmina Alatovic+49 (0)
6131 9084 1513Media@biontech.de
Investor RelationsVictoria Meissner,
M.D.Investors@biontech.de
BioNTech (NASDAQ:BNTX)
過去 株価チャート
から 8 2024 まで 9 2024
BioNTech (NASDAQ:BNTX)
過去 株価チャート
から 9 2023 まで 9 2024
